MiraBiologics
Latest round
- Series A
Last raised
- Jan 2020
Total raised
- $5M
Investors
- 3
About MiraBiologics
MiraBiologics Inc.Founded in 2017 and headquartered in Tokyo, Japan, MiraBiologics Inc. specializes in biopharmaceutical innovations.MiraBiologics Inc. specializes in the development of innovative Neobiologics, which are multifunctional biopharmaceuticals created using their proprietary LassoGraft Technology®. This technology involves grafting target-specific cyclic peptides onto proteins in the body, thereby transforming these proteins into biologically active entities capable of addressing a range of therapeutic needs. The company's product offerings aim to extend the boundaries of biopharmaceuticals, catering to a diverse clientele that includes pharmaceutical companies and healthcare providers seeking advanced treatment options for various medical conditions. These offerings are designed to serve patients globally, with a focus on regions where there is a high demand for advanced therapies, including North America, Europe, and parts of Asia.MiraBiologics Inc. operates on a partnership model that emphasizes collaboration with pharmaceutical companies to expedite the drug development process. Revenue generation occurs primarily through strategic alliances, leveraging its LassoGraft Technology® alongside the expertise of its partners in the biopharmaceutical sector. Transactions typically involve contractual agreements that may include performance milestones and co-development arrangements. While specific pricing information for their products and services is not disclosed, the company’s flagship offerings, which fall under the category of Neobiologics, are priced based on the complexity and uniqueness of the technology applied.MiraBiologics Inc. The company is focused on launching new Neobiologics and expanding into North America and Europe by 2022. This growth strategy will involve enhancing their LassoGraft Technology® to develop additional therapeutic products, ensuring they meet the rising demand for innovative biopharmaceutical solutions.
Who invested in MiraBiologics
3 investors across 1 round
See all investors in MiraBiologics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 15, 2020
Amount
$5M
Investors
Questions about MiraBiologics
Who invested in MiraBiologics?
MiraBiologics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has MiraBiologics raised?
MiraBiologics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did MiraBiologics last raise money?
MiraBiologics's most recent round on record is a Series A, in Jan 2020.
What does MiraBiologics do?
MiraBiologics is a biotechnology company.
Where is MiraBiologics headquartered?
MiraBiologics is headquartered in Tokyo, Japan.
Which VCs invest in companies like MiraBiologics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at MiraBiologics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like MiraBiologics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.